(AMRN) Community Analysis from
Bulls REASONS TO BUY
|
93%
agree
16 votes
|
After Anchor, Value Realization |
Bears REASONS TO SELL
May 21, 2013
(Stock Blog Hub,
1/23/13)
Amarin Corporation plc (AMRN), recently announced that the notice of patent allowance for US application serial number 13/610,217 has been published by the US Patent and...(read more)
(market folly,
4/16/12)
Steve Cohen
's hedge fund
SAC Capital
filed a 13G with the SEC regarding its position in Amarin (AMRN). Per the filing, the firm now owns 5.3% of the company with 7,216,209 shares.
This marks a...(read more)
(ValueWalk.com,
4/16/12)
Several major investors made moves in the pharmaceuticals arena last week as the ups and downs in that industry came to the fore. The Baupost Group sold off...(read more)
Amarin (AMRN) Company Overview
There is no analysis for AMRN yet. But you can go to Wikinvest to help create one!
